What question did this study set out to answer?

To assess the effectiveness of a Meds-to-Beds program in reducing unplanned hospitalizations following PCI.

March 28, 2026Open Access

Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary Intervention

Resultado clave

Meds-to-Beds programs and other health system interventions aimed at reducing unplanned readmissions after percutaneous coronary intervention are currently not well described.

Puntos clave

To assess the effectiveness of a Meds-to-Beds program in reducing unplanned hospitalizations following PCI.
Evaluation of a Meds-to-Beds program implementation.
Analysis of readmission rates after PCI.
Comparison of costs associated with readmissions.
Identification of high readmission rates post-PCI.
Evidence of cost-saving opportunities.
Potential improvement in patient outcomes after intervention.

PICO estructurado

Does a Meds-to-Beds Program reduce readmissions in patients following percutaneous coronary intervention?

Población

Patients following percutaneous coronary intervention (PCI)

Intervención

Meds-to-Beds Program

Resultado

Readmissions

Resultado numérico

Tasa de eventos absoluta: 0% vs 0%

Resumen

Unplanned hospitalizations following percutaneous coronary intervention (PCI) are common and represent an opportunity to improve outcomes and reduce costs. However, health system interventions to reduce readmissions in this population are not well described.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo